Cytek Biosciences (CTKB) Competitors $3.94 +0.04 (+1.03%) Closing price 04:00 PM EasternExtended Trading$3.94 +0.00 (+0.13%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CTKB vs. TXG, EYPT, AEHR, ALNT, TRNS, LAB, SENS, QSI, FEIM, and MASSShould you be buying Cytek Biosciences stock or one of its competitors? The main competitors of Cytek Biosciences include 10x Genomics (TXG), Eyepoint Pharmaceuticals (EYPT), Aehr Test Systems (AEHR), Allient (ALNT), Transcat (TRNS), Standard BioTools (LAB), Senseonics (SENS), Quantum-Si (QSI), Frequency Electronics (FEIM), and 908 Devices (MASS). These companies are all part of the "measuring and control equipment" industry. Cytek Biosciences vs. Its Competitors 10x Genomics Eyepoint Pharmaceuticals Aehr Test Systems Allient Transcat Standard BioTools Senseonics Quantum-Si Frequency Electronics 908 Devices 10x Genomics (NASDAQ:TXG) and Cytek Biosciences (NASDAQ:CTKB) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk, media sentiment and dividends. Which has preferable earnings and valuation, TXG or CTKB? Cytek Biosciences has lower revenue, but higher earnings than 10x Genomics. Cytek Biosciences is trading at a lower price-to-earnings ratio than 10x Genomics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio10x Genomics$610.78M2.39-$182.63M-$0.70-16.73Cytek Biosciences$200.45M2.50-$6.02M-$0.05-78.80 Do analysts recommend TXG or CTKB? 10x Genomics presently has a consensus target price of $13.65, indicating a potential upside of 16.60%. Cytek Biosciences has a consensus target price of $5.60, indicating a potential upside of 42.13%. Given Cytek Biosciences' stronger consensus rating and higher possible upside, analysts clearly believe Cytek Biosciences is more favorable than 10x Genomics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 10x Genomics 2 Sell rating(s) 8 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.25Cytek Biosciences 2 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.29 Do insiders & institutionals believe in TXG or CTKB? 84.7% of 10x Genomics shares are owned by institutional investors. Comparatively, 69.5% of Cytek Biosciences shares are owned by institutional investors. 9.4% of 10x Genomics shares are owned by insiders. Comparatively, 10.3% of Cytek Biosciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is TXG or CTKB more profitable? Cytek Biosciences has a net margin of -3.27% compared to 10x Genomics' net margin of -13.13%. Cytek Biosciences' return on equity of -1.66% beat 10x Genomics' return on equity.Company Net Margins Return on Equity Return on Assets 10x Genomics-13.13% -12.88% -10.03% Cytek Biosciences -3.27%-1.66%-1.30% Which has more volatility & risk, TXG or CTKB? 10x Genomics has a beta of 2.05, indicating that its share price is 105% more volatile than the S&P 500. Comparatively, Cytek Biosciences has a beta of 1.31, indicating that its share price is 31% more volatile than the S&P 500. Does the media favor TXG or CTKB? In the previous week, 10x Genomics had 2 more articles in the media than Cytek Biosciences. MarketBeat recorded 8 mentions for 10x Genomics and 6 mentions for Cytek Biosciences. Cytek Biosciences' average media sentiment score of 0.93 beat 10x Genomics' score of 0.83 indicating that Cytek Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment 10x Genomics 2 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cytek Biosciences 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryCytek Biosciences beats 10x Genomics on 11 of the 17 factors compared between the two stocks. Get Cytek Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CTKB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CTKB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CTKB vs. The Competition Export to ExcelMetricCytek BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$496.17M$3.37B$6.14B$10.65BDividend YieldN/A2.29%5.66%4.70%P/E Ratio-78.8021.3485.8427.65Price / Sales2.50488.69626.36141.34Price / Cash112.3947.1938.3262.20Price / Book1.2810.4313.066.79Net Income-$6.02M-$52.40M$3.30B$275.88M7 Day Performance7.95%6.36%4.81%2.64%1 Month Performance0.25%16.14%9.99%9.13%1 Year Performance-21.67%33.90%85.28%35.89% Cytek Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CTKBCytek Biosciences2.3717 of 5 stars$3.94+1.0%$5.60+42.1%-22.6%$496.17M$200.45M-78.80500News CoverageAnalyst UpgradeTXG10x Genomics3.8967 of 5 stars$11.34-3.2%$13.65+20.4%-40.0%$1.46B$610.78M-16.201,240High Trading VolumeEYPTEyepoint Pharmaceuticals1.4978 of 5 stars$14.05+1.1%$26.86+91.2%+63.7%$958.09M$51.90M-5.24120News CoverageAnalyst ForecastAEHRAehr Test Systems1.6434 of 5 stars$30.45+0.9%N/A+106.0%$904.76M$58.97M-234.2190News CoverageEarnings ReportAnalyst DowngradeGap DownALNTAllient2.8527 of 5 stars$43.28-1.2%$35.00-19.1%+152.4%$742.28M$519.60M50.332,525Analyst ForecastTRNSTranscat3.5877 of 5 stars$72.73-1.3%$112.20+54.3%-40.6%$686.82M$278.42M50.861,245News CoverageAnalyst UpgradeLABStandard BioTools2.4744 of 5 stars$1.27-2.3%$1.55+22.0%-26.7%$496.59M$172.27M-3.97620News CoveragePositive NewsAnalyst ForecastSENSSenseonics2.2829 of 5 stars$0.44-3.8%$1.54+247.5%+37.5%$360.50M$25.47M-3.4090News CoverageGap UpQSIQuantum-Si2.4373 of 5 stars$1.39-6.7%$3.48+150.0%+111.4%$301.72M$3.06M-2.04150Analyst ForecastFEIMFrequency Electronics2.5634 of 5 stars$32.09+6.6%$43.00+34.0%+215.3%$293.55M$69.81M14.01200Positive NewsAnalyst ForecastMASS908 Devices1.8549 of 5 stars$8.15+1.7%$8.00-1.8%+162.9%$287.25M$59.63M-15.0960Analyst Forecast Related Companies and Tools Related Companies 10x Genomics Alternatives Eyepoint Pharmaceuticals Alternatives Aehr Test Systems Alternatives Allient Alternatives Transcat Alternatives Standard BioTools Alternatives Senseonics Alternatives Quantum-Si Alternatives Frequency Electronics Alternatives 908 Devices Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CTKB) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytek Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cytek Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
